Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
|2||Active, not recruiting||
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
International Lymphatic Disease and Lymphedema Registry
† Study has passed its completion date and status has not been verified in more than two years.